Literature DB >> 6996625

Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.

J A Smith, A G Skidmore, A D Forward, A M Clarke, E Sutherland.   

Abstract

In a prospective, double-blind study, clindamycin was compared with metronidazole, each combined with tobramycin and all by the intravenous route in the treatment of intra-abdominal sepsis. Twenty-three patients received clindamycin and 34 patients received 35 courses of metronidazole. Analysis of the clinical responses of patients indicates that the two antibiotic regiments are of equal efficacy in that there was no difference between them in terms of defervescence or duration of infection. Few adverse effects were noted, and all appeared to be of a minor nature.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6996625      PMCID: PMC1344856          DOI: 10.1097/00000658-198008000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Anaerobic specimen transport device.

Authors:  T D Wilkins; F Jimenez-Ulate
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

2.  THE BACTERIAL FLORA OF ACUTE PERFORATED APPENDICITIS WITH PERITONITIS: A BACTERIOLOGIC STUDY BASED UPON ONE HUNDRED CASES.

Authors:  W A Altemeier
Journal:  Ann Surg       Date:  1938-04       Impact factor: 12.969

3.  The optimum duration of systemic antibiotic administration in the treatment of experimental peritonitis.

Authors:  D Law; C Law; J K Todd; B Eiseman
Journal:  Aust N Z J Surg       Date:  1977-02

4.  Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis.

Authors:  A B Onderdonk; T J Louie; F P Tally; J G Bartlett
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

5.  Metronidazole and anaerobic sepsis.

Authors:  S J Eykyn; I Phillips
Journal:  Br Med J       Date:  1976-12-11

6.  Antimicrobial therapy of experimental intraabdominal sepsis.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; T J Louie; S L Gorbach
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

7.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

8.  Bactericidal activity of metronidazole against Bacteroides fragilis.

Authors:  J P Whelan; J H Hale
Journal:  J Clin Pathol       Date:  1973-06       Impact factor: 3.411

9.  Metronidazole in prevention and treatment of bacteroides infections after appendicectomy.

Authors:  A T Willis; I R Ferguson; P H Jones; K D Phillips; P V Tearle; R B Berry; R V Fiddian; D F Graham; D H Harland; D B Innes; W M Mee; R L Rothwell-Jackson; I Sutch; C Kilbey; D Edwards
Journal:  Br Med J       Date:  1976-02-07

10.  Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy.

Authors:  D A Leigh
Journal:  Br Med J       Date:  1974-07-27
View more
  10 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  Cost-effective choice of antimicrobial therapy for serious infections.

Authors:  M C Weinstein; J L Read; D N MacKay; J J Kresel; H Ashley; K T Halvorsen; H C Hutchings
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

Review 3.  Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

Authors:  J L Ho; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 4.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting.

Authors:  J S Solomkin; J L Meakins; M D Allo; E P Dellinger; R L Simmons
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

Review 6.  Primary and secondary peritonitis: an update.

Authors:  M Laroche; G Harding
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

7.  Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes.

Authors:  F Namavar; A M Verweij; M Bal; T J van Steenbergen; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.

Authors:  J J Schentag; P B Wels; D P Reitberg; P Walczak; J H Van Tyle; R J Lascola
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

9.  Intravenous metronidazole for treatment of infections involving anaerobic bacteria.

Authors:  W L George; B D Kirby; V L Sutter; L A Wheeler; M E Mulligan; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

10.  A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.

Authors:  F P Tally; K McGowan; J M Kellum; S L Gorbach; T F O'Donnell
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.